WHO Approves Johnson & Johnson COVID-19 Vaccine For Emergency Use

Hamilton Nwosa
Writer
905m COVID-19 Shots Administered Worldwide – Report

Ad

U.S. Oil Output Beats Weekly Estimates in June

U.S. crude oil production hit a new record in June at 13.58 million barrels per day, according to the Energy Information Administration’s latest Petroleum Supply Monthly. That’s 133,000 barrels more than May and 2.5 percent higher than a year ago. The new monthly figures also show a sharp disconnect from the EIA’s weekly estimates. For…

Zelenskyy fumes as ex-Ukrainian parliament speaker is shot dead

By Obinna Uballa Ukrainian President Volodymyr Zelenskyy has condemned the killing of former parliament speaker Andriy Parubiy as a “horrendous murder,” vowing that every resource will be deployed to track down the attacker. “All necessary forces and means are engaged in the investigation and search for the killer,” Zelenskyy said in a statement on social…

Rivers Crisis: Fubara will return as governor after September 18, Wike declares

• Hails LG election as peaceful By Obinna Uballa Minister of the Federal Capital Territory (FCT), Nyesom Wike, has assured that Rivers State Governor, Siminalayi Fubara, and the State House of Assembly will resume their constitutional duties once the emergency rule in the state expires on September 18. Wike, who spoke to journalists on Saturday…

Ad

The World Health Organization (WHO) on Friday approved Johnson & Johnson’s Covid-19 vaccine, after already authorising the jabs made by Pfizer-BioNTech and Oxford-AstraZeneca.

“Every new, safe and effective tool against Covid-19 is another step closer to controlling the pandemic,” WHO chief Tedros Adhanom Ghebreyesus said in a statement.

The news comes after the single-dose jab won approval from the European Union on Thursday.

It has also received the green light from regulators in the United States, Canada and South Africa.

The World Health Organization said the Johnson & Johnson’s Covid-19 vaccine had been granted an “emergency use listing” which assesses the suitability of new health products during public health emergencies, and is quicker than the regular licensing system.

WHO authorisation paves the way for the jabs to be used as part of the Covax initiative aimed at ensuring equitable access to vaccines in poorer countries.

Some 500 million doses of the J&J jabs have been promised to the facility and the WHO hopes it can be rolled out through the scheme from July, if not earlier.

“We hope this new vaccine will help to narrow vaccine inequalities, and not deepen them,” Tedros told a briefing.

Clinical trials have found that the J&J shot was 67 percent effective at preventing people from getting Covid-19.

But that result considered all forms of Covid-19. The jab proved 85.4 percent effective at preventing severe disease.

And since this is a single-dose jab, WHO said it expected it to facilitate vaccination logistics in all countries.

“The sample data from large clinical trials shared by the company also shows that the vaccine is effective in older populations,” it said.

AFP

Ad

X whatsapp